Patent Yard Sign in
Canadian application, no grantCanada

Apoptosis promoting and suppressing substances interacting with cgi-94, and methods for screening the same

CA 2433180 A1 · Owner: Yamada, Takashi · Inventors: Yamada, Takashi; Heese, Klaus; Sawada, Tohru

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention provides substances which suppress or promote apoptosis of nerve cells, methods far screening them and methods for diagnosis and treatment of diseases associated with apoptosis and kits therefore. Specifically the present, invention provides suppress or promote functions of CGI-94 protein or the interaction of CGI-94 protein with Smac/DIABLO to suppress or promote apoptosis. In addition the present, invention also provides a p18TFP protein and its coding DNA as an apoptosis suppressing substance, and pharmaceutical compositions for treating diseases associated with apoptosis which comprises said protein or DNA.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 19, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 19, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 19, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 19, 2003
GrantedNo grant recorded
Term endedFebruary 19, 2023
Patent numberCA 2433180 A1
Classification (IPC)C12N15/12 +2 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedFeb 19, 2003Term endedFeb 19, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.